Trademark: 90455676
Word
VAXTEXT
Status
Dead
Status Code
602
Status Date
Wednesday, September 28, 2022
Serial Number
90455676
Mark Type
3000
Filing Date
Friday, January 8, 2021
Abandoned Date
Monday, September 19, 2022

Trademark Owner History

Classifications
38 Text messaging services featuring vaccine information, reminders, safety alerts, and helplines
35 Electronic data collection and analysis for business purposes in the fields of vaccination administration, research, management, and follow-up care; Data processing services in the fields of vaccination administration, research, management, and follow-up care, including but not limited to Covid-19; Electronic data collection and analysis for business purposes in the fields of vaccination administration, research, management, and follow-up care; Data processing services in the fields of vaccination administration, research, management, and follow-up care, including but not limited to Covid-19; Doctors' and other health care professionals appointment reminder services related to receiving vaccines; Doctors' and other healthcare professionals appointment reminder services related to receiving vaccines, including but not limited to Covid-19
45 Providing personalized public safety alerts related to vaccine schedules
44 Providing healthcare information; providing personalized healthcare and medical information in the nature of vaccine information and medical public health guidance online and via cell phone SMS; interactive medical monitoring and alert service for medical treatment purposes for reminding individuals about vaccination schedules, assessing vaccine responses, side effects, injuries, and allergic sensitivities, and offering medical treatment options; providing healthcare information about vaccines via a global internet website and via mobile phone SMS; Medical screening information services featuring reminder alerts that individuals should receive vaccines for preventive care purposes; interactive medical monitoring and alert service for medical treatment purposes for reminding individuals about vaccination schedules; telemedicine services; providing personalized healthcare and medical information in the nature of vaccine information and medical public health guidance online and via mobile phone SMS, including but not limited to Covid-19; Medical screening information services featuring reminder alerts that individuals should receive vaccines for preventive care purposes, including but not limited to Covid-19; interactive medical monitoring and alert service for medical treatment purposes for reminding individuals about vaccination schedules, including but not limited to Covid-19; interactive medical monitoring and alert service for medical treatment purposes for reminding individuals about vaccination schedules, assessing vaccine responses, side effects, injuries, and allergic sensitivities, and offering medical treatment options, including but not limited to Covid-19; providing healthcare information about Covid-19 vaccines via a global internet website and via mobile phone SMS; interactive medical monitoring and alert service for medical treatment purposes for reminding individuals about vaccine schedules and side effects, including but not limited Covid-19; electronic data collection and analysis, namely, monitoring, analysis, and reporting of medical data in the fields of vaccination administration, research, management, and follow-up care; electronic data collection and analysis, namely, monitoring, analysis, and reporting of medical data in the fields of vaccination administration, research, management, and follow-up care, including but not limited to Covid-19
42 electronic data collection and analysis, namely, monitoring and reporting of scientific data in the fields of vaccination administration, research, management, and follow-up care; Electronic data storage, in the fields of vaccination administration, research, management, and follow-up care; electronic data collection and analysis, namely, monitoring and reporting of medication reminder data in the fields of vaccination administration, research, management, and follow-up care, including but not limited to Covid-19
The mark consists of the wording "VAXTEXT", with an incomplete speech bubble with the letter "V" inside and the letter "A" spanning the opening in the right side.
VAX TEXT

Trademark Events
Sep 28, 2022
Abandonment Notice E-Mailed - Failure To Respond
Sep 28, 2022
Abandonment Notice Mailed - Failure To Respond
Sep 28, 2022
Abandonment - Failure To Respond Or Late Response
Mar 16, 2022
Notification Of Non-Final Action E-Mailed
Mar 16, 2022
Non-Final Action E-Mailed
Mar 16, 2022
Non-Final Action Written
Mar 11, 2022
Previous Allowance Count Withdrawn
Feb 22, 2022
Withdrawn From Pub - Og Review Query
Feb 7, 2022
Approved For Pub - Principal Register
Feb 7, 2022
Examiner's Amendment Entered
Feb 7, 2022
Notification Of Examiners Amendment E-Mailed
Feb 7, 2022
Examiners Amendment E-Mailed
Feb 7, 2022
Examiners Amendment -Written
Jan 14, 2022
Teas/Email Correspondence Entered
Jan 13, 2022
Correspondence Received In Law Office
Jan 13, 2022
Teas Response To Office Action Received
Jul 13, 2021
Notification Of Non-Final Action E-Mailed
Jul 13, 2021
Non-Final Action E-Mailed
Jul 13, 2021
Non-Final Action Written
Jul 7, 2021
Assigned To Examiner
Apr 9, 2021
Notice Of Design Search Code E-Mailed
Apr 8, 2021
New Application Office Supplied Data Entered In Tram
Jan 25, 2021
Teas Change Of Correspondence Received
Jan 25, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 25, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 12, 2021
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24